期刊文献+

微小RNA对心房颤动离子通道调节机制的研究进展

下载PDF
导出
摘要 心房颤动是临床上最常见的心律失常之一,其发病率随年龄增长而增加,我国成人心房颤动患病率约为0.77%,80岁人群的患病率为5%~15%[1]。心房颤动心电图特征为P波消失,代之以不规则起伏的基线和心室QRS波。心房各部分肌纤维极不协调的颤动影响心房有效收缩,导致心室律(率)紊乱、心功能受损和血栓形成,是引起脑卒中、心力衰竭及死亡的重要原因,有很高的致死率和致残率[2,3]。心房颤动发生和维持极其复杂,虽然近年来对心房颤动发生机制进行了一些研究,但学术界仍然对一些现象和理论存在分歧,目前其发病机制还没有完全清楚。
出处 《中国药物与临床》 CAS 2015年第10期1435-1437,共3页 Chinese Remedies & Clinics
基金 国家自然科学基金(81370304) 国家人社部和南京市留学回国人员科技活动择优资助项目(2014) 江苏省自然科学基金(BK20151085)
  • 相关文献

参考文献3

二级参考文献30

  • 1[1]Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report[J].Circulation,2002,106(25):3143-3142.
  • 2[2]Gotto AM Jr,Whitney E,Stein EA,et al.Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/Tex-CAPS)[J].Circulation,2000,101(5):477-484.
  • 3[3]Kleemann R,Princen HM,Emeis JJ,et al.Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE-Lei-den transgenic mice:evidence for antiinflammatory effects of rosuvastatin[J].Circulation,2003,108 (11):1368-1374.
  • 4[4]Albert MA,Danielson E,Rifai N,et al.Effect of statin therapy on C-reactive protein levels.,the pravastatin inflammation/CRP evaluation (PRINCE):a randomized trial and cohort study[J].JAMA,2001,286(1):64-70.
  • 5[5]Ridker PM,Cannon CP,Morrow D,et al.C-reactive protein levels and outcomes after statin therapy[J].N Engl J Med,2005,352(1):20-28.
  • 6[6]Nissen SE,Tuzcu EM,Schoenhagen P,et al.Statin therapy,LDL cholesterol,C-reactive protein,and coronary artery disease[J].N Engl J Med,2005,352(1):29-38.
  • 7[7]Ridker PM,JUPITER Study Group.Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity Creactive protein:rationale and design of the JUPITER trial[J].Circulation,2003,108(19):2292-2297.
  • 8[8]von Haehling S,Anker SD,Bassenge E.Statins and the role of nitric oxide in chronic heart failure[J].Heart Fail Rev,2003,8(1):99-106.
  • 9[9]Liao JK.Beyond lipid lowering:the role of statins in vascular protection[J].Int J Cardiol,2002,86(1):5-18.
  • 10[10]Laufs U,Gertz K,Huang P,et al.Atorvastatin upregulates type Ⅲ nitric oxide synthase in thromhocytes,decreases platelet activation,and protects from cerebral ischemia in normocholesterolemic mice[J].Stroke,2000,31(10):2442-2449.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部